TAYLOR TUTEN: Open Payments
NPI 1073282075 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 24 payments from 9 companies in 2025. Trend: 2023 $60 · 2024 $343 · 2025 $460
Food & beverage: $460
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 6 | $115 |
| GENZYME CORPORATION | 4 | $101 |
| Biogen, Inc. | 5 | $91 |
| Lundbeck LLC | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Valinor Pharma, LLC | 2 | $33 |
| ABBVIE INC. | 1 | $15 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
| EMD Serono, Inc. | 1 | $14 |
Products named: Belbuca, TYSABRI, VYEPTI, RELISTOR, MOVANTIK, QULIPTA, REXULTI.
Industry payments across LA — which companies pay providers there.
